Governance Implications of the New Department of Justice Compliance Effectiveness Guidelines
- October 04, 2024
- Michael W. Peregrine , McDermott Will & Emery LLP
- Ashley C. Hoff , McDermott Will & Emery LLP
Health care corporate boards, and their Audit & Compliance Committees, should take heed of the latest revisions of the Department of Justice’s (DOJ’s) Evaluation of Corporate Compliance Programs (ECCP) guidance, released on September 23. This is particularly important as boards consider a more robust oversight approach to the company’s use of emerging technology, such as artificial intelligence.
ARTICLE TAGS
You must be logged in to access this content.